| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.1M | +138.5% |
| SG&A Expense | $4.8M | +50.7% |
| Operating Income | -$7.9M | -39.5% |
| Income Tax | $0 | — |
| Net Income | -$8.9M | -57.0% |
| EPS (Basic) | -$7.84 | +60.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.6M | +531.6% |
| Inventory | $0 | -100.0% |
| Current Assets | $13.0M | +392.8% |
| Total Assets | $31.6M | +1026.0% |
| Current Liabilities | $646K | +137.5% |
| Total Liabilities | $7.4M | +2635.3% |
| Stockholders' Equity | $16.8M | +562.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.0M | -22.3% |
| Capital Expenditures | $38K | — |
| Investing Cash Flow | -$705K | — |
| Financing Cash Flow | $18.3M | +323.5% |
| Free Cash Flow | -$7.0M | -22.9% |